Bioactive micropatterned platform to engineer myotube-like cells from stem cells

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Cell Biology

Background:

• Skeletal muscle possesses self-healing capabilities, but severe injuries and myopathies impair this ability.
• Stem cell-based therapies offer potential for restoring muscle function after damage.
• Current methods for directing stem cell differentiation require optimization for therapeutic applications.

Purpose of the Study:

• To develop a bioactive, gold micropatterned platform to promote human mesenchymal stem cell (hMSC) differentiation into myotube-like cells.
• To investigate the role of integrin-β1 (ITG-β1) signaling and cell anisotropy in hMSC myogenesis.
• To establish an in vitro model for studying stem cell differentiation relevant to muscle regeneration.

Main Methods:

• Immobilization of integrin-β1 antibody onto a gold micropatterned surface.
• Culture of human mesenchymal stem cells (hMSCs) on the developed bioactive micropattern.
• Analysis of cell differentiation using myogenic markers, multinucleation, proliferation markers, and immunofluorescence microscopy.
• Assessment of focal adhesions and stress fiber formation.

Main Results:

• hMSCs differentiated into myotube-like cells within two weeks on the bioactive micropattern.
• Confirmed myotube formation through upregulation of myogenic markers, multinucleation, and continuous actin cytoskeleton.
• Observed elongated ITG-β1 focal adhesions and anisotropic stress fibers in differentiated cells.
• Demonstrated absence of proliferation markers, indicating successful differentiation.

Conclusions:

• The developed bioactive micropattern effectively promotes hMSC differentiation into myotube-like cells.
• Engineered cell anisotropy and ITG-β1 signaling play synergistic roles in stem cell myogenesis.
• This platform provides a promising tool for regenerative medicine strategies targeting skeletal muscle repair.